Countries North America
Promontory Therapeutics Exceeds Interim Efficacy Bar In Thymoma Study With PT 112
Three of the first 10 patients with thymoma evaluated by RECIST have partial responses. Findings exceed protocol requirement of two re...
December 24, 2025 | News
NeuroSense Reports Clean Safety Profile From Phase 2 PrimeC Study In Alzheimer’s Disease
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for&nbs...
December 24, 2025 | News
Samsung Biologics Acquires GSK Rockville Facility To Establish First US Manufacturing Site
- Secures the company’s first U.S.-based manufacturing site, strengthening and diversifying its global supply network - Additional investments plann...
December 22, 2025 | News
Soin Neuroscience And BIOTRONIK Neuro Advance Personalised Spinal Cord Stimulation Research
Soin Neuroscience and BIOTRONIK Neuro announced a research collaboration to advance personalized spinal cord stimulation (SCS) tuning using Soin Neuroscien...
December 22, 2025 | News
Atom Therapeutics Secures FDA Approval To Advance Phase II Trial Of ABP 745 In Atherosclerosis
Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA ...
December 18, 2025 | News
Sanofi And Dren Bio Expand Strategic Collaboration To Advance Next Generation B Cell Depleting Therapies In Autoimmune Disease
– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engag...
December 17, 2025 | News
ALZpath Licenses pTau217 Antibody To Siemens Healthineers To Expand Blood Based Alzheimer’s Diagnostics
ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer’s disease and related dementias, announced a licensing ag...
December 17, 2025 | News
Thermo Fisher Scientific Advances Microbial Bioprocessing With Chemically Defined Media For Confident Plasmid DNA And Protein Scale Up
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence Thermo Fisher Scientific In...
December 16, 2025 | News
AusperBio Reports 30% Functional Cure Rate With AHB 137 In Chronic Hepatitis B
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing oli...
December 16, 2025 | Report
Sapu Nano Unveils Biomarker Signature Predicting Sensitivity to Intravenous Sapu003
Sapu Nano announced new biomarker data identifying a molecular signature that predicts sensitivity to Sapu003, the company’s intravenous D...
December 08, 2025 | News
Sabin Vaccine Institute Sends 640+ Investigational cAd3-Marburg Vaccine Doses to Ethiopia for Rapid Outbreak Response
The Sabin Vaccine Institute (Sabin) has sent more than 640 doses of its investigational cAd3-Marburg Vaccine to Ethiopia to support the country’s res...
December 08, 2025 | News
Kelun Biotech And Crescent Biopharma Forge Global Partnership To Advance Next Generation Oncology Therapies
Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets an...
December 05, 2025 | News
AGC Biologics Strengthens Global Cell Line Capabilities With ATUM Partnership and Leap In Technology
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex mole...
December 04, 2025 | News
Generate Plans Global Phase 3 Trials for AI Engineered GB 0895 in Severe Asthma
Generate:Biomedicines ("Generate") announced it plans to initiate two global Phase 3 clinical trials, SOLAIRIA-1 and SOLAIRIA-2, evaluating GB-0895 in appr...
December 02, 2025 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
